سعر Sinuobuster 665 mcg/100 microlitre nasal spray 2026

Sinuobuster olopatadine nasal spray, 665 mcg per 100 microlitre spray, 240 metered doses, listed under Global Napi Pharmaceuticals / Novell Pharma (Egypt); an H1-receptor antagonist.

• Seasonal allergic rhinitis symptomsPopulation: Adults and children >=6 yearsDailyMed (U.S. National Library of Medicine)

• Most common (>1%), age 12+: bitter taste, headache, epistaxis, pharyngolaryngeal pain, post-nasal drip, cough, urinary tract infection; age 6-11: epistaxis, headache, upper respiratory infection, bitter taste, pyrexia, rash.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• None stated in the US label.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Epistaxis, nasal ulceration and nasal septal perforation: examine the nose before and periodically during treatment; avoid in nasal disease other than allergic rhinitis.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• Somnolence: avoid hazardous activities requiring full alertness; avoid alcohol and other CNS depressants.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Alcohol and other CNS depressantsAdditional reduction in alertness; avoid concurrent use.DailyMed (U.S. National Library of Medicine)

• Postmarketing data with similar antihistamines have not identified a drug-associated risk of major birth defects or miscarriage; no human data specific to olopatadine nasal spray; animal studies at very high oral doses reduced live fetuses.International label, same formulation · DailyMed (U.S. National Library of Medicine)
• No data on presence in human milk; consider the benefits of breastfeeding with the mother's clinical need.International label, same formulation · DailyMed (U.S. National Library of Medicine)

• Olopatadine (as hydrochloride): Selective histamine H1-receptor antagonist.